According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2023 the company made an earning of NZ$2.96 Million a decrease over its 2022 earnings that were of NZ$45.92 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | NZ$2.96 M | -93.55% |
2022 | NZ$45.92 M | -3.43% |
2021 | NZ$47.55 M | -418.87% |
2020 | -NZ$14.92 Million | -64.28% |
2019 | -NZ$41.75 Million | 19.49% |
2018 | -NZ$34.94 Million | -48.67% |
2017 | -NZ$68.08 Million | -234.57% |
2016 | NZ$50.58 M | -89.6% |
2015 | NZ$0.48 B | 110.02% |
2014 | NZ$0.23 B | 33.75% |
2013 | NZ$0.17 B | 177.69% |
2012 | NZ$62.35 M | 201.84% |
2011 | NZ$20.65 M | 99.1% |
2010 | NZ$10.37 M | -22.14% |
2009 | NZ$13.32 M | -53.08% |
2008 | NZ$28.39 M | 7167.3% |
2007 | NZ$0.39 M | -66.41% |
2006 | NZ$1.16 M | -57.18% |
2005 | NZ$2.71 M | -193.84% |
2004 | -NZ$2.9 Million |